Closed call for evidence

Drug use in ethnic minority groups: call for evidence

Updated 21 September 2023

This was published under the 2022 to 2024 Sunak Conservative government

© Crown copyright 2023

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/calls-for-evidence/drug-use-in-ethnic-minority-groups/drug-use-in-ethnic-minority-groups-call-for-evidence

ACMD Chair: Professor Owen Bowden-Jones
ACMD Recovery Committee Secretary: Matthew Brace
1st Floor (NE), Peel Building
2 Marsham Street
London
SW1P 4DF

ACMD@homeoffice.gov.uk

21 August 2023

Dear Sir or Madam,

Call for evidence – Drug Use in Ethnic Minority Groups Review

The Advisory Council on the Misuse of Drugs (ACMD) has previously investigated vulnerability and risk factors to developing drug dependence [footnote 1] and vulnerability of specific groups including young people [footnote 2], homeless [footnote 3], and LGBT communities [footnote 4]. Following this work, the ACMD has agreed to begin a self-commissioned workstream investigating drug use in ethnic minority groups.

The aim of this report is to consider the evidence regarding prevalence of drug use in ethnic minority groups, challenges facing the reporting and engagement in and access to treatment services.

The ACMD would be grateful for your response as part of a public call for evidence by Friday 27 October 2023.

We welcome submissions of evidence from as broad a spectrum of participants as possible and would therefore be grateful if you could please circulate this call for evidence to other colleagues and relevant stakeholders.

The ACMD will use this evidence to assist in formulating advice to government.

Yours sincerely,

[signed]

Professor Owen Bowden-Jones

Chair of the ACMD

[signed]

Professor Anne Campbell

Co-Chair of the ACMD Recovery Committee

[signed]

Dr Emily Finch

Co-Chair of the ACMD Recovery Committee

Footnotes:

  1. Vulnerabilities and substance use: ACMD report - GOV.UK (www.gov.uk) ↩

  2. ACMD vulnerable groups: young people’s drug use - GOV.UK (www.gov.uk) ↩

  3. Drug-related harms in homeless populations - GOV.UK (www.gov.uk) ↩

  4. Assessment of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds - GOV.UK (www.gov.uk) ↩

Back to top